---
title: "Guangdong Taienkang Pharmaceutical Co.,Ltd. (301263.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301263.SZ.md"
symbol: "301263.SZ"
name: "Guangdong Taienkang Pharmaceutical Co.,Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-21T23:17:45.569Z"
locales:
  - [en](https://longbridge.com/en/quote/301263.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301263.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301263.SZ.md)
---

# Guangdong Taienkang Pharmaceutical Co.,Ltd. (301263.SZ)

## Company Overview

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and sanitary materials, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.tai-kang.com.cn](https://www.tai-kang.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: C (0.54)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 0 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.00% |  |
| Net Profit YoY | 0.00% |  |
| P/B Ratio | 6.64 |  |
| Dividend Ratio | 0.75% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 11237020198.84 |  |
| Revenue | 673191643.98 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 1.33% | D |
| Profit Margin | 3.45% | C |
| Gross Margin | 58.82% | B |
| Revenue YoY | -10.31% | E |
| Net Profit YoY | -82.71% | E |
| Total Assets YoY | 5.30% | C |
| Net Assets YoY | -0.85% | D |
| Cash Flow Margin | 166.10% | B |
| OCF YoY | -10.31% | E |
| Turnover | 0.29 | D |
| Gearing Ratio | 24.84% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Guangdong Taienkang Pharmaceutical Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "0.00%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "6.64",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.75%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "11237020198.84",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "673191643.98",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "1.33%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "3.45%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "58.82%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-10.31%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-82.71%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "5.30%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.85%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "166.10%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-10.31%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.29",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "24.84%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 438.10 | 163/215 | 540.78 | 473.55 | 174.80 |
| PB | 6.63 | 199/215 | 8.56 | 7.65 | 6.89 |
| PS (TTM) | 16.54 | 204/215 | 21.73 | 19.66 | 17.64 |
| Dividend Yield | 0.75% | 114/215 | 0.70% | 0.64% | 0.56% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-02-24T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 26.28 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/301263.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/301263.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/301263.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/301263.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**